Phototoxic effect of fluoroquinolones on two human cell lines.
Photosensitization induced by the fluoroquinolone ofloxacin (OFLX) has been studied using two human cell lines, HL60 and K562, two UV wavelengths, 290 and 330 nm, and two different exposure protocols, acute and protracted. The examined endpoints are the cellular lethality and recovery and the membrane changes produced by the oxidative damage, studied using cloning and counting techniques and the measurement of the generalized polarization (GP) of the fluorescent membrane probe 2-dimethylamino-6-lauroyl-naphthalene (Laurdan). The results show that: (i) the photosensitizing effect is detectable at concentrations similar to those found in patients treated with OFLX only when the cells are irradiated with 330 nm; (ii) the amount of photodamage is a function of the drug concentration and of UV dose and persists also after the removal of the drug; (iii) during the first 24 h after OFLX treatment, a large decrease of the cell number can be observed due to cell lysis; (iv) the OFLX is inserted in the cell membranes at concentrations directly related with the drug concentration and incubation time; (v) the OFLX produces an increase in the GP values similar to that produced by membrane lipid oxidation which persists for hours after the removal of the drug. The overall results suggest the cell membrane as the main target of the OFLX adverse action, with a possible mechanism involving the formation of reactive oxygen species (ROS), which triggers, in turn, the lipid peroxidation chain reaction.
Trisciuoglio
D
D
Laboratorio di Tossicologia Comparata ed Ecotossicologia, Istituto Superiore di Sanità, Viale regina Elena 299, 00161 Rome, Italy.
Krasnowska
E
E
Maggi
A
A
Pozzi
R
R
Parasassi
T
T
Sapora
O
O
D000890:Anti-Infective Agents / Q000633:toxicity*; D016923:Cell Death; D002462:Cell Membrane / Q000187:drug effects / Q000473:pathology; D004912:Erythrocytes; D018922:HL-60 Cells; D006801:Humans; D015227:Lipid Peroxidation; D015242:Ofloxacin / Q000633:toxicity*; D018384:Oxidative Stress; D010787:Photosensitivity Disorders; D014466:Ultraviolet Rays / Q000009:adverse effects*
D000890:Anti-Infective Agents; D015242:Ofloxacin